Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Femasys (FEMY) Common Equity (2024 - 2025)

Femasys' Common Equity history spans 2 years, with the latest figure at $5.9 million for Q4 2025.

  • For Q4 2025, Common Equity rose 154.7% year-over-year to $5.9 million; the TTM value through Dec 2025 reached $5.9 million, up 154.7%, while the annual FY2025 figure was $5.9 million, 154.7% up from the prior year.
  • Common Equity reached $5.9 million in Q4 2025 per FEMY's latest filing, up from $4.6 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $15.6 million in Q1 2024 to a low of $1.5 million in Q2 2025.